Skip to main content
Premium Trial:

Request an Annual Quote

Deltagen and Pfizer Sign Gene Function Database Agreement

NEW YORK, Dec 22 - Deltagen said Friday that it has signed Pfizer as the second licensee to its DeltaBase gene function database.

Under the terms of the agreement, Pfizer will have non-exclusive access to in vivo mammalian gene function information on 750 genes in DeltaBase, as well as access to corresponding DeltaBase intellectual property rights.

The initial term of the agreement is three years, through June 30, 2003, with the option to extend the term for two additional years. Pfizer will have access to 250 genes per year.

Pfizer elected to license all previous data releases under DeltaBase. Deltagen will receive $15 million in license access fees, with up to $25 million possible with term extensions. Other financial terms of the agreement were not disclosed.

“We believe that DeltaBase will become an integral part of the pharmaceutical R&D process by providing researchers with the capacity to translate raw genomic sequence into information on the function, disease relevance and potential commercial value of a particular gene," said Bill Matthews, president and CEO of Deltagen, in a statement.

DeltaBase contains functional and phenotypic information for genes that have been chosen for their ability to be useful targets for drug discovery.

Deltagen signed Glaxo Wellcome as its first DeltaBase subscriber in September under similar terms.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.